Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018

BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare Conference. The Conference is taking place November 14-15, 2018 in London, UK.

Jason Grenfell-Gardner, Chief Executive Officer of Teligent, Inc., will present on Wednesday November 14th at 11:20 a.m. GMT+1. 

The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Contact:   Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
     

Teligent.jpg



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today